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Dendritic Cells―A Conductor of T Cell
Differentiation―
Norimitsu Kadowaki1
ABSTRACT
Induction of different types of adaptive immune responses depending on the nature of antigens and the envi-
ronmental context is crucial to cope with a variety of pathogens and concurrently to avoid pathological reaction
to self antigens. Recent studies have been elucidating that the diversity of immune responses is critically con-
trolled by dendritic cells (DCs). Two DC subsets have been identified in humans: myeloid DCs and plasmacy-
toid DCs. The DC subsets induce different types of adaptive immune responses depending on environmental
factors. Interleukin (IL)-12 from myeloid DCs is a dominant factor for the induction of a Th1 response, whereas
OX40 ligand on myeloid DCs is important for the induction of a Th2 response. Furthermore, inducible costimu-
lator (ICOS) ligand on plasmacytoid DCs is critical for the induction of IL-10-producing regulatory T cells. Eluci-
dating cellular and molecular mechanisms by which functions of the two DC subsets are modulated will lead to
understanding the pathogenesis of various immune-related diseases and to developing novel immunological
therapies.
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INTRODUCTION
The immune system has evolved to eliminate a vari-
ety of microbial pathogens and at the same time to
avoid responding to self antigens and innocuous anti-
gens. Elucidating how this demanding task is accom-
plished is the main theme of immunology. Recent
studies have been revealing that dendritic cells (DCs)
are deeply involved in the process of differential re-
sponses to different types of antigens.1
During innate immune responses at the site of in-
fection, immature DCs located in inflamed tissues in-
corporate pathogens, and become activated in re-
sponse to pathogens themselves and proinflamma-
tory cytokines. Thereafter, the activated (also called
mature) DCs migrate to draining lymph nodes and
stimulate naïve T cells to differentiate into function-
ally competent effector T cells. Importantly, such T
cell responses, especially those of CD4+ T helper
(Th) cells, are heterogeneous; naïve CD4+ T cells dif-
ferentiate into effector Th cells that produce different
combinations of cytokines. These divergent Th cell
responses, the prototypes of which are called Th1
and Th2 responses, induce different types of immune
responses appropriate to eliminate given pathogens.
Furthermore, recent studies have shown that another
type of Th cells, called Th17 cells, develops under the
influence of IL-23, transforming growth factor (TGF)-
β, and IL-6, and play a key role in promoting autoin-
flammatory disorders as well as immunity against ex-
tracellular bacteria.2 On the other hand, naïve CD4+
T cells are able to develop into immunosuppressive T
cells that inhibit immune responses to self antigens.3
How these different types of T cell responses are in-
duced after the interaction with DCs is an important
issue to understand the pathogenesis of various
immune-related disorders and to develop novel im-
munological therapies.
In humans, DCs are composed of two subsets:
myeloid DCs (mDCs) and plasmacytoid DCs (pDCs).
Recent studies have revealed that these DC subsets
perform different functions in both innate and adap-
tive immune responses. At the same time, both of the
DC subsets have functional plasticity to induce appro-
priate T cell responses depending on the types of
stimuli. In this review, we discuss the diversity of DC
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subsets, mainly in humans, from the perspective of
their roles in adaptive immune responses.
HUMAN DC SUBSETS
In human peripheral blood, two DC subsets have
been recognized based on the expression of CD11c.4
The CD11c+ cells in blood express myeloid markers
such as CD13, CD33, and CD11b,4 whereas the
CD11c− cells do not express significant levels of
myeloid markers.4 Freshly isolated CD11c− cells have
plasmacytoid morphology with well developed rough
endoplasmic reticulum and Golgi apparatus.5 The
CD11c+ DCs are generally called myeloid DCs
(mDCs) based on the expression of myeloid markers,
whereas CD11c− DCs are called plasmacytoid DCs
(pDCs) based on its plasmacytoid morphology at the
DC precursor stage.
In addition to these primary DC-committed cells, it
is well established that monocytes differentiate into
immature DCs in the presence of granulocyte-
macrophage colony stimulating-factor (GM-CSF) plus
IL-4,6 or GM-CSF plus interferon (IFN)-α.7 It has
been reported that mDCs in blood develop macro-
phage morphology as well as the expression of bu-
tyrate esterase and CD14 in response to M-CSF,8 sug-
gesting that at least a subpopulation of mDCs in
blood is capable of differentiating into macrophages
and is thus related to monocyte-derived DCs in terms
of cellular origin. However, the precise relationship
between mDCs in blood and monocyte-derived DCs
remains to be determined. Here we designate
CD11c+ mDCs in peripheral blood as “blood mDCs”,
and blood mDCs and monocyte-derived DCs (as well
as mouse myeloid DCs) collectively as “myeloid
DCs”.
Importantly, pDC precursors exhibit distinct ex-
pression profiles of Toll-like receptors (TLRs) com-
pared with monocytes and blood mDCs.9 Strong ex-
pressions of mRNA were found in monocytes for
TLR1, TLR2, TLR4, TLR5, and TLR8; in blood mDCs
for TLR1, TLR2, TLR3, and TLR5; in pDC precursors
for TLR7 and TLR9. Thus, myeloid APCs share sev-
eral TLRs, whereas pDCs express distinct TLRs. Ac-
cordingly, myeloid APCs (monocytes and blood
mDCs) mainly recognize bacterial components and
produce proinflammatory cytokines TNF-α, IL-6, IL-
12, whereas pDC precursors mainly recognize viral
components and produce a large amount of type I
IFNs.
MYELOID DCS RESPOND TO BROAD
RANGE OF MICROBES IN ADAPTIVE IM-
MUNE RESPONSES
The human immune system has evolved to have two
separate mechanisms for protection against different
types of microbes. In response to intracellular mi-
crobes, such as bacteria, viruses, and intracellular
parasites, DCs are induced to produce IL-12 and type
I IFNs.10,11 These activated DCs can then stimulate
CD4+ Th cells to differentiate into IFN-γ-producing
Th1 cells.12,13 The activated Th1 cells, in turn, help to
activate macrophages and CD8+ cytotoxic T cells to
kill intracellular microbes. In response to extracellu-
lar parasites, such as helminthes, CD4+ Th cells are
activated and induced by activated DCs to differenti-
ate into Th2 cells.10,14,15 Th2 cells produce proallergic
cytokines such as IL-4, IL-5, and IL-13, which trigger
IgE production. IgE, in turn, activates mast cells and
eosinophils to eradicate the extracellular microbes.
Recent studies have shown that DCs play a critical
role in directing different effector T cell re-
sponses.12,16 Myeloid DC subsets have a capacity to
produce IL-12 in response to the microbial stimuli
and, thereby, to induce Th1 development. Consistent
with the paradigm of two types of immune responses
(Th1 versus Th2) mentioned above, however, this ca-
pacity varies with the type of signals delivered to DCs
(Figs. 1A, B). For example, LPS derived from Es-
cherichia coli,17,18 peptidoglycan from gram-positive
bacteria,9,18,19 Mycobacterium tuberculosis,20 Toxoplas-
ma gondii,21,22 Candida albicans at the yeast stage,23
and double-stranded viral RNA,9,24,25 all activate
myeloid DCs to produce IL-12 and to induce Th1 de-
velopment, whereas LPS from Porphyromonas gin-
givalis,17,26 Candida albicans at the hyphae stage,23
Der p 1 (house dust mite allergen),27,28 and Schistoso-
ma mansoni egg extract,24,29,30 all activate myeloid
DCs to induce Th2 development, which is associated
with a lower capacity of the DCs to induce IL-12.
Thus, different microbes and their components in-
duce myeloid DCs to produce different levels of IL-
12, which leads to different types of Th responses ap-
propriate to eliminate given pathogens.
Environmentally bioactive substances produced by
inflammatory processes that act as a cAMP upregula-
tor, such as prostaglandin (PG) E230 and histamine,31
enhance TNF-α-dependent myeloid DC maturation
but suppresses bioactive IL-12 p70 production, result-
ing in Th2 responses (Fig. 1A).
DCs and mast cells co-localize in peripheral tissues
of antigen entry, i.e. skin and mucosa. Due to the
proximity of these two cell types, activation of mast
cells may affect DC functions. Indeed, we showed
that IgE-activated mast cells in combination with
proinflammatory factors, such as LPS, IFN-γ, and
TNF-α, induce Th2-promoting dendritic cells, using
human monocyte-derived DCs and cord blood-
derived mast cells (Fig. 1A).32 Activated MCs in-
duced maturation of DCs, and potently suppressed
interleukin-12p70 production by the DCs. A combina-
torial effect of various MC-derived factors, including
histamine and those acting in a cell contact-
dependent manner, was required for the optimal in-
duction of Th2-promoting DCs. Thus, the interaction
between DCs and IgE-activated mast cells in a proin-
flammatory environment may be instrumental in
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Fig. 1 Human DC subsets induce diferent types of CD4 ＋ Th cel responses depending on environmental factors. (A) During in-
nate immune responses, monocytes produce proinflammatory factors, such as TNF-α and IL-6, in response to bacterial compo-
nents through TLRs. Thereafter, monocyte-derived DCs induced by GM-CSF and IL-4 produce IL-12 in response to certain 
microbes, and thus induce a Th1 response. In contrast, monocyte-derived DCs stimulated with mast cels or PGE2 together with 
proinflammatory factors induce a Th2 response. (B) Myeloid DCs produce IL-12 in response to bacterial or viral components 
through TLRs and thus induce a Th1 response. In contrast, myeloid DCs stimulated with TSLP induce a Th2 response through 
the interaction between OX40 ligand and OX40. (C) During innate immune responses, plasmacytoid DC precursors produce a 
large amount of IFN-α in response to viral components through TLR7 and TLR9. Thereafter, plasmacytoid DCs stimulated with 
viruses induce IL-10-producing cytotoxic regulatory T cels, whereas plasmacytoid DCs stimulated with IL-3 induce a Th2 re-
sponse through the interaction between OX40 ligand and OX40. Moreover, ICOS ligand on plasmacytoid DCs is responsible for 
the induction of IL-10 by T cels, which is important for an immunoregulatory function of the T cels. PGN: peptidoglycan, LPS: 
lipopolysaccharides, dsRNA: double-stranded RNA, ssRNA: single-stranded RNA.
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maintaining and augmenting Th2 responses in al-
lergy.
Thymic stromal lymphopoietin (TSLP), an IL-7-like
cytokine, may be a key physiological mediator that
cause allergic inflammation through DCs. TSLP
strongly activates human blood mDCs to upregulate
costimulatory molecules and to secrete the Th2-
attracting chemokines TARC and MDC, but neither
IL-12 nor pro-inflammatory cytokines.33,34 These
TSLP-activated DCs in turn induce allogeneic naïve
CD4+ T cells to undergo robust proliferation and to
differentiate into Th2 cells capable of secreting large
amounts of IL-4, IL-5, IL-13, and TNF-α (Fig. 1B).
These findings, together with high TSLP expression
in keratinocytes from the skin lesions of patients with
atopic dermatitis,34 suggest that TSLP plays a critical
role in the initiation of allergic inflammation.
Immunosuppressive cytokines such as IL-10 and
TGF-β, as well as steroid, cyclosporin A, and 1-α, 25-
dihydoxyvitamin D3, inhibit the maturation of
myeloid DCs as well as their IL-12 production.35-40
These DCs cannot drive DC-mediated Th1Tc1 re-
sponses but rather induce DC-mediated regulatory T
cells (or possibly Th2 cells), similar to the immature
steady-state DCs.41,42 Interestingly, a recent study
has shown that vitamin D3 activated by skin DCs in-
duces CCR10 on T cells, resulting in their migration
to epidermis.43 Thus, the same factor (vitamin D3)
can inhibit or promote T cell responses through the
different mode of action.
Taken together, myeloid DCs are capable of induc-
ing naïve CD4+ T cells to differentiate into Th1, Th2,
and even regulatory T cells, depending on the stimuli
the DCs receive from the environment.
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pDCIPCs REGULATE T CELL RESPONSES
UPON VIRAL INFECTION AND IL-3 MILIEU
pDCs, also referred to type I interferon (IFN-αβω)-
producing cells (IPCs), are the key effectors in the in-
nate immune system because of their extraordinary
capacity to produce type I IFNs upon microbial infec-
tion, particularly viral infection.44,45 Following the in-
nate response phase, pDCIPCs can switch their
functional properties from cytokine producers to ma-
ture DCs to directly modulate T cell functions. Signal-
ing through TLR7 and TLR9 by viruses or by syn-
thetic CpG-oligodeoxynucleotide (ODN) can stimu-
late pDCIPCs to produce IFN-αβ and rapidly un-
dergo maturation.46-48 pDCIPCs possess little phago-
cytic activity,5,49 and pDC-derived DCs induced by
CpG-ODN can prime CD8+ T cell responses to only
endogenous antigens but not to exogenous anti-
gens.50 These results suggest that pDC-derived DCs
may function mainly to present viral or endogenous
antigens to T cells. In fact, during influenza viral in-
fection, pDC-derived DCs appear to be capable of
priming viral-specific primary and secondary CD4+
and CD8+ T cell immune responses in vitro and in
vivo.51,52
Virus-stimulated pDCs induce human naïve CD4+
allogeneic T cells to differentiate into IFN-γ- and IL-
10-producing cells,46 which appear to have an im-
munoregulatory function (Fig. 1C).53 In contrast to vi-
ral and CpG-ODN stimulation, IL-3 can trigger pDCs
to develop into mature DCs in the presence of CD40L
but to produce no type I IFNs and then prime naïve
CD4+ T cells to produce IL-4, IL-5, and IL-10 (Fig. 1
C).5,46 The biological significance of pDC differentia-
tion into mature DCs in the presence of IL-3 is un-
clear. It has been proposed that IL-3 may be pro-
duced by basophils, eosinophils, and mast cells dur-
ing parasite infection, and the pDC-derived DCs may
initiate anti-parasite Th2 immune responses.
Several studies have indicated tolerogenic func-
tions of pDCs. The pDCs induced by IL-3 with CD40L
prime naïve CD8+ T cells to differentiate into IL-10-
producing suppressor T cells, which inhibit by-
stander proliferation of CD8+ T cells in an IL-10-
dependent manner.54 Recent studies have shown
that, in humans, freshly isolated pDC precursors in-
duce CD4+ T cell anergy55 and pDC-derived DCs acti-
vated by CpG-ODN prime naïve CD4+ T cells to dif-
ferentiate into CD4+CD25+ regulatory T cells charac-
terized as Foxp3+ IL-10-producing suppressor T
cells.56 We have also shown that virus-stimulated
pDCs induce naïve CD4+ T cells to differentiate into
IFN-γ- and IL-10-producing cytotoxic regulatory T
cells that express granzymes and perforin (Fig. 1C).53
Thus, pDCs that have been stimulated with various
stimuli induce IL-10-producing regulatory T cells.
It has been shown that mouse pDCs express CD40
ligand, which activates mDCs to produce IL-12
through CD40 that is induced by IL-15 upon stimula-
tion with CpG DNA.57 Thus, other than through IFN-
α production, pDCs augment immune responses by
cross-talking with mDCs with the help of CD40
ligand and IL-15.
DC-DERIVED DECISIVE FACTORS FOR DIF-
FERENT TYPES OF TH RESPONSES
It is well established that IL-12 represents a dominant
inducer of a Th1 response. However, in IL-12-
deficient mice infected with Toxoplasma gondii, Th1
responses are impaired but still observed to some ex-
tent.58 This indicates that some factors other than IL-
12 are responsible for the residual Th1 induction. A
recent study has shown that CD70 expressed on
mouse DEC-205+ mDCs represents such an IL-12-
independent Th1-inducing factor.59 Also it remains to
be clarified how DCs instruct Th2 differentiation, that
is, whether Th2 differentiation is caused by a default
fate in the absence of IL-12, or requires a positive Th2
-instructive signal. IL-4 is an important factor for Th2
differentiation.14 However, Th2 differentiation can oc-
cur without IL-4 produced by non-T cells.60 In addi-
tion, there is no evidence that any DCs produce IL-4.
Furthermore, IL-12-deficient mice infected with
Toxoplasma gondii fail to develop Th2 responses.58
Accordingly, signals other than IL-4 may presumably
instruct Th2 differentiation.
It has been demonstrated in the mouse system that
APCs use two types of Notch ligands (Delta and Jag-
ged) to regulate Th cell differentiation. Bone marrow-
derived DCs treated with LPS strongly express Notch
ligand Delta, which contributes to Th1-inducing activ-
ity of the DCs.61,62 Meanwhile, DCs exposed to cAMP
upregulators PGE2 and cholera toxin preferentially
express Notch ligand Jagged, which instructs naïve
CD4+ T cells to differentiate Th2 cells independently
of IL-4.61
Several studies have emphasized the role of OX40
ligand (OX40L), a member of the TNF superfamily,
in triggering the development and maintenance of
Th2 cells in mice and humans.63-66 Schistosoma man-
soni egg extract induces human monocyte-derived
DCs to express OX40L, which contributes to the
priming of Th2 cells.24 Furthermore, an OX40L-
dependent mechanism is functional in pDC-mediated
Th2 responses (Fig. 1C). pDC-derived DCs induced
by IL-3 or a virus express considerable levels of
OX40L, and blockade of OX40L significantly inhibited
the ability of DCs to prime naïve CD4+ T cells to pro-
duce IL-4, IL-5 and IL-13.67 OX40L on mDCs activated
by TSLP is also responsible for Th2 differentiation of
responding CD4+ T cells (Fig. 1B).68
It has been shown that ICOS ligand highly ex-
pressed on pDCs is responsible for the IL-10 produc-
tion by T cells (Fig. 1C).69 This finding indicates that
pDCs have an intrinsic ability to induce IL-10-
producing regulatory T cells by expressing ICOS
T Cell Differentiation Induced by DCs
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ligand, which discriminates pDCs from mDCs.
Recent studies have revealed the importance of IL-
17-producing CD4+ T cells, Th17 cells, in autoim-
mune diseases, such as experimental allergic en-
cephalitis (EAE) and arthritis, as well as in immune
responses against extracellular bacteria.2 Th17 cells
are induced by TGF-β and IL-6, and IL-23 promotes
the induction of Th17 cells. Human monocyte-derived
DCs stimulated with intact E. coli together with ATP
that binds to purinergic P2 receptors produce IL-23
and thus promote the induction of IL-17-producing
CD4+ T cells.70 Mouse CD11b+ myeloid DCs in the
central nervous system are capable of producing IL-
23, TGF-β, and IL-6, and thus induce Th17 cells in an
EAE model.71 Therefore, depending on the environ-
mental factors and possibly on DC subsets, particular
types of DCs may preferentially induce Th17 cells. It
needs to be further investigated how human and
mouse DCs are involved in the differentiation of
naïve CD4+ T cells into Th17 cells in various patho-
logical conditions.
Collectively, multiple factors, including Th1-, Th2-,
and possibly Th17-instructing signals from DC sub-
sets, may dictate the quality of T cell responses in dif-
ferent immunopathological conditions.
CONCLUSION
In host defense, many of the “danger signals” of in-
fection are integrated by DCs and then converted into
appropriate immune responses. In this context, not
only do different types of DCs have their own poten-
tial to initiate innate and adaptive immune responses,
but also even the same type of DCs can induce differ-
ent immune responses depending on the environ-
mental pathogenic stimuli. The molecular events re-
sponsible for the crosstalk between DCs and T cells
still need to be clarified. The specialized roles of each
DC subset in innate and adaptive immune responses
have been well characterized in this decade. In the fu-
ture, further knowledge of the molecular mecha-
nisms that control functional plasticity of the DC sys-
tem may lead to improvements in the treatment of a
wide variety of diseases, such as cancers, infections,
allergy, and autoimmune disorders.
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